Ricardo Grieshaber-Bouyer, MD, PhD

University Hospital Erlangen
Erlangen, Germany

Professor of Clinical Systems Immunology and Head of the Clinical Trial Unit, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen

Presentation(s):

• 0236: Safety and Efficacy of T Cell Engager Therapy in patients with refractory Autoimmune Disease

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.

• 2641: Cizutamig, a BCMA T-cell engager: preclinical to clinical translation of design optimization for the treatment of autoimmune diseases

  Wednesday, October 29, 2025
  10:00 AM - 10:15 AM Central Time

  Disclosure information not submitted.